Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Portsmouth | OTHER |
| Institute of Bioengineering and Bioimaging (IBB) | OTHER_GOV |
| Loughborough University | OTHER |
Not provided
Not provided
Not provided
Not provided
Type 2 diabetes mellitus (T2DM) is a metabolic condition characterized by chronic hyperglycemia and progressive insulin resistance, which progressively lead to macro- and microvascular damage. With the number of people with T2DM continuing to rise, this pandemic is expected to reach 700 million people by 2045, such that the costs associated with its clinical management are likely to become unsustainable. Therefore, identifying cost effective alternative interventions is imperative.
Diets rich in fruits and vegetables are well known to have cardiovascular benefits and reduce the risk of getting T2DM. The beneficial effects of vegetables on cardiovascular outcomes are particularly effective in green leafy vegetables and beetroot. This may in part be due to a high concentration of inorganic nitrate, and its beneficial effects on cardiovascular health due to its effect on nitric oxide (NO•). Increased dietary nitrate intake elevates cyclic guanosine monophosphate [(cGMP)]. Importantly, cGMP has also been shown to increase brown fat expression by 'beiging' WAT in mice through an NO• dependent process.
Recent developments in the ability to non-invasively measure BAT activation using magnetic resonance imaging (MRI) and infrared thermography (ITR) has opened the possibility to study the effects of nitrate on BAT activation in man. BAT depots in humans with T2DM have been identified using MRI but not yet with the more easily accessible technique of IRT.
It is hypothesised that nitrate can increase BAT activation and quantity in people with T2DM.
Dietary inorganic nitrate is converted in a reversible, stepwise reaction to nitrite via bacteria on the dorsum of the tongue. Subsequently, small quantities of NO• are produced in the stomach. The remaining nitrite is then absorbed into the circulation where it acts as a storage pool for subsequent NO• production. Production of NO• from nitrite reduction is expedited in hypoxaemia, a phenomenon observed in the vasculature of white adipose tissue (WAT).
WAT is primarily an energy store, whereas brown adipose tissue (BAT) is a metabolically active tissue. BAT is responsible for ~5% of basal metabolic rate and ~15% of total energy expenditure, equating to ~40 g of BAT per day and is used in non-shivering thermogenesis. BAT is used for heat production and is stimulated by cold environments and or diet to cause thermogenesis. To produce heat during cold exposure, uncoupling protein (UCP)-1, an inner mitochondrial protein, is upregulated in BAT ultimately uncoupling the mitochondrial proton gradient, making the cell less energy efficient. Inorganic nitrate supplementation has also been shown to increase UCP-1 expression in BAT.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental: Beetroot juice then nitrate depleted beetroot juice | Experimental | Participants will be asked to consume 140ml of beetroot juice prior to their first experimental visit. Participants will then be asked to consume 140ml a day for 2 weeks, and finally visit the investigators once more following another 140ml drink. |
|
| Experimental: Nitrate depleted beetroot juice then beetroot juice | Experimental | Participants will be asked to consume 140ml of placebo prior to their first experimental visit. Participants will then be asked to consume 140ml a day for 2 weeks, and finally visit the investigators once more following another 140ml drink. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Concentrated beetroot juice | Dietary Supplement | Acute and chronic supplementation of beetroot juice. |
|
| Measure | Description | Time Frame |
|---|---|---|
| MRI Imaging of Supraclavicular BAT | High-resolution 3-dimensional T1-weighted imaging will be acquired using repetition time, echo time and field of view. All imaging sequences will have anatomical coverage of the neck, supraclavicular region and the apices of the lung. | MRI on day 14 (Visit 2) before 60 minutes of cold exposure, following 14-days beetroot/placebo supplementation with 7-day washout between crossover. |
| MRI Imaging of Supraclavicular BAT | High-resolution 3-dimensional T1-weighted imaging will be acquired using repetition time, echo time and field of view. All imaging sequences will have anatomical coverage of the neck, supraclavicular region and the apices of the lung. | MRI on day 14 (Visit 2) following 60 minutes of cold exposure, following 14-days beetroot/placebo supplementation with 7-day washout between crossover. |
| MRI Imaging of Supraclavicular BAT | High-resolution 3-dimensional T1-weighted imaging will be acquired using repetition time, echo time and field of view. All imaging sequences will have anatomical coverage of the neck, supraclavicular region and the apices of the lung. | MRI on day 35 (visit 3) before 60 minutes of cold exposure, following 14-days beetroot/placebo supplementation with 7-day washout between crossover. |
| MRI Imaging of Supraclavicular BAT | High-resolution 3-dimensional T1-weighted imaging will be acquired using repetition time, echo time and field of view. All imaging sequences will have anatomical coverage of the neck, supraclavicular region and the apices of the lung. | MRI on day 35 (visit 3) following 60 minutes of cold exposure, following 14-days beetroot/placebo supplementation with 7-day washout between crossover. |
| A 3D multi-point Dixon sequence will be utilized for the water-fat imaging. |
| Measure | Description | Time Frame |
|---|---|---|
| IRT Imaging of Supraclavicular BAT | Bilaterally, two regions will be analysed for skin temperature from thermal images using infrared cameras: 1) the skin area overlaying BAT in the SCV fossae on the left and right sides, and; 2) the sternal area considered as a control. | IRT on day 14 (Visit 2) and day 35 (visit 3), before and after 60 minutes of cold water immersion, following 14-days beetroot/placebo supplementation with 7-day washout between crossover. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Rebecc Neal | Senior Lecturer in Exercise Physiology | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Bournemouth University | Bournemouth | Dorset | BH12 5BB | United Kingdom | ||
| University of Portsmouth |
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Double blind randomised control trial. Supplements will be dispensed by a member of the research team.
| Nitrate depleted beetroot juice | Dietary Supplement | (Nitrate depleted beetroot juice |
|
A 3D multi-point Dixon sequence will be utilized for the water-fat imaging.
| At start of MRI Imaging of Supraclavicular BAT |
| A 3D multi-point Dixon sequence will be utilized for the water-fat imaging. | A 3D multi-point Dixon sequence will be utilized for the water-fat imaging. | At end of MRI Imaging of Supraclavicular BAT |
| Pixel wise quantification of fat fraction will be performed from fat and water maps. | Pixel wise quantification of fat fraction will be performed from fat and water maps. | At time of MRI Imaging |
| Biomarkers - Nitrate | Quantified using a Sievers nitric oxide analyser | Blood sampling on day 14 (Visit 2) and day 35 (visit 3) following 14-days beetroot/placebo supplementation with 7-day washout between crossover. |
| Biomarkers - Nitrite | Quantified using a Sievers nitric oxide analyser | Blood sampling on day 14 (Visit 2) and day 35 (visit 3) following 14-days beetroot/placebo supplementation with 7-day washout between crossover. |
| Biomarkers - cGMP | Quantified using a Sievers nitric oxide analyser | Blood sampling on day 14 (Visit 2) and day 35 (visit 3) following 14-days beetroot/placebo supplementation with 7-day washout between crossover. |
| Biomarkers - Nitrate | Quantified using commercially available ELISA assays | Blood sampling on day 14 (Visit 2) and day 35 (visit 3) following 14-days beetroot/placebo supplementation with 7-day washout between crossover. |
| Biomarkers - Nitrite | Quantified using commercially available ELISA assays | Blood sampling on day 14 (Visit 2) and day 35 (visit 3) following 14-days beetroot/placebo supplementation with 7-day washout between crossover. |
| Biomarkers - cGMP | Quantified using commercially available ELISA assays | Blood sampling on day 14 (Visit 2) and day 35 (visit 3) following 14-days beetroot/placebo supplementation with 7-day washout between crossover. |
| Portsmouth |
| Hampshire |
| PO1 2UP |
| United Kingdom |
| Southern Health NHS Foundation Trust | Southampton | Hampshire | SO40 8DX | United Kingdom |
| Shore Medical | Poole | United Kingdom |
| D004700 | Endocrine System Diseases |